These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 31516612)
41. Comparison of Picosecond and Nanosecond Nd:YAG 1064-nm Lasers in the Treatment of Melasma: A Split-Face Randomized Clinical Trial. Feng J; Huang L Plast Reconstr Surg; 2023 Apr; 151(4):772-777. PubMed ID: 36729879 [TBL] [Abstract][Full Text] [Related]
42. Oral tranexamic acid enhances the efficacy of low-fluence 1064-nm quality-switched neodymium-doped yttrium aluminum garnet laser treatment for melasma in Koreans: a randomized, prospective trial. Shin JU; Park J; Oh SH; Lee JH Dermatol Surg; 2013 Mar; 39(3 Pt 1):435-42. PubMed ID: 23278870 [TBL] [Abstract][Full Text] [Related]
43. Treatment of Postinflammatory Pigmentation Due to Acne with Q-Switched Neodymium-Doped Yttrium Aluminum Garnet In 78 Indian Cases. Zawar VP; Agarwal M; Vasudevan B J Cutan Aesthet Surg; 2015; 8(4):222-6. PubMed ID: 26865787 [TBL] [Abstract][Full Text] [Related]
44. Clinical Study of a Q-Switched Neodymium-Doped Yttrium Aluminum Garnet Laser with Different Parameters in the Treatment of Chloasma: A Randomized-Controlled Trial. Pan J; Zhao JH; Lv YW; Zeng SW; Zhao JY; Gao FL Photobiomodul Photomed Laser Surg; 2022 Mar; 40(3):183-188. PubMed ID: 35298285 [No Abstract] [Full Text] [Related]
45. Pilot Study to Demonstrate Improvement in Skin Tone and Texture by Treatment with a 1064 nm Q-Switched Neodymium-Doped Yttrium Aluminum Garnet Laser. Munavalli GS; Leight-Dunn HM J Clin Med; 2024 Feb; 13(5):. PubMed ID: 38592205 [TBL] [Abstract][Full Text] [Related]
46. The removal of cutaneous pigmented lesions with the Q-switched ruby laser and the Q-switched neodymium: yttrium-aluminum-garnet laser. A comparative study. Tse Y; Levine VJ; McClain SA; Ashinoff R J Dermatol Surg Oncol; 1994 Dec; 20(12):795-800. PubMed ID: 7798410 [TBL] [Abstract][Full Text] [Related]
47. Beneficial Effect of Low Fluence 1,064 nm Q-Switched Neodymium:Yttrium-Aluminum-Garnet Laser in the Treatment of Senile Lentigo. Nam JH; Kim HS; Lee GY; Kim WS Ann Dermatol; 2017 Aug; 29(4):427-432. PubMed ID: 28761290 [TBL] [Abstract][Full Text] [Related]
48. Q-Switched Neodymium-Doped Yttrium Aluminum Garnet laser therapy for pigmented skin lesions: efficacy and safety. Karn D; K C S; Amatya A; Razouria EA; Timalsina M; Suwal A Kathmandu Univ Med J (KUMJ); 2012; 10(38):46-50. PubMed ID: 23132475 [TBL] [Abstract][Full Text] [Related]
49. Efficacy and Safety of Topical Silymarin Versus Low Fluence 1064-nm Q Switched Nd:YAG Laser in the Treatment of Melasma: A Comparative Randomized Trial. Ibrahim SMA; Farag AS; Ali MS; El-Gendy WMAF Lasers Surg Med; 2021 Dec; 53(10):1341-1347. PubMed ID: 34101206 [TBL] [Abstract][Full Text] [Related]
50. Formation of new melasma lesions in the periorbital area following high-fluence, 1064-nm, Q-switched Nd/YAG laser. Lee WJ; Kim YJ; Noh TK; Chang SE J Cosmet Laser Ther; 2013 Jun; 15(3):163-5. PubMed ID: 23656545 [TBL] [Abstract][Full Text] [Related]
51. Induction of melasma by 1064-nm Q-switched neodymium:yttrium-aluminum-garnet laser therapy for acquired bilateral nevus of Ota-like macules (Hori nevus): A study on related factors in the Chinese population. Wang B; Xie HF; Tan J; Xie HJ; Xu LY; Ding R; Liu FF; Chen X; Jian D; Li J J Dermatol; 2016 Jun; 43(6):655-61. PubMed ID: 26777390 [TBL] [Abstract][Full Text] [Related]
52. Low-fluence Q-switched 1,064-nm neodymium-doped yttrium aluminum garnet laser for the treatment of facial partial unilateral lentiginosis in Koreans. Lee Y; Choi EH; Lee SW Dermatol Surg; 2012 Jan; 38(1):31-7. PubMed ID: 22093176 [TBL] [Abstract][Full Text] [Related]
53. Q-switched Nd: YAG laser alone or with modified Jessner chemical peeling for treatment of mixed melasma in dark skin types: A comparative clinical, histopathological, and immunohistochemical study. Saleh F; Moftah NH; Abdel-Azim E; Gharieb MG J Cosmet Dermatol; 2018 Jun; 17(3):319-327. PubMed ID: 29057567 [TBL] [Abstract][Full Text] [Related]
54. Dual Toning Method with the Combination of Picosecond and Microsecond Nd:YAG in Refractory Melasma Unresponsive to Picosecond Alone. Hai L; Phuong B; Ha L; Lam V; Van B; Al-Niaimi F J Cutan Aesthet Surg; 2021; 14(1):101-106. PubMed ID: 34084016 [TBL] [Abstract][Full Text] [Related]
55. The Clinical and Histological Effect of a Low-Fluence Q-Switched 1,064-nm Neodymium: Yttrium-Aluminum-Garnet Laser for the Treatment of Melasma and Solar Lentigenes in Asians: Prospective, Randomized, and Split-Face Comparative Study. Kaminaka C; Furukawa F; Yamamoto Y Dermatol Surg; 2017 Sep; 43(9):1120-1133. PubMed ID: 28328709 [TBL] [Abstract][Full Text] [Related]
56. Fractional, nonablative Q-switched 1,064-nm neodymium YAG laser to rejuvenate photoaged skin: a pilot case series. Luebberding S; Alexiades-Armenakas MR J Drugs Dermatol; 2012 Nov; 11(11):1300-4. PubMed ID: 23135078 [TBL] [Abstract][Full Text] [Related]
57. A case of mottled hypopigmentation after low-fluence 1,064-nm Q-switched neodymium-doped yttrium aluminum garnet laser therapy. Ryu HJ; Kim J J Cosmet Laser Ther; 2013 Oct; 15(5):290-2. PubMed ID: 23464754 [TBL] [Abstract][Full Text] [Related]
58. A Split-Face, Single-Blinded, Randomized Controlled Comparison of 532 nm Picosecond Neodymium-Doped Yttrium Aluminum Garnet Laser versus 532 nm Q-Switched Neodymium-Doped Yttrium Aluminum Garnet Laser in the Treatment of Solar Lentigines. Kim JY; Yang J; Huh G; Choi YJ; Kim WS Ann Dermatol; 2020 Feb; 32(1):8-13. PubMed ID: 33911703 [TBL] [Abstract][Full Text] [Related]
59. In vivo trial comparing patients' tolerance of Q-switched Alexandrite (QS Alex) and Q-switched neodymium:yttrium-aluminum-garnet (QS Nd:YAG) lasers in the treatment of nevus of Ota. Chan HH; King WW; Chan ES; Mok CO; Ho WS; Van Krevel C; Lau WY Lasers Surg Med; 1999; 24(1):24-8. PubMed ID: 10037348 [TBL] [Abstract][Full Text] [Related]
60. Comparative effectiveness and safety of topical methimazole 5% monotherapy versus combination of Q-Switched Nd: YAG Laser and topical methimazole 5% in patients with refractory melasma. Beyzaee AM; Goldust M; Rokni GR; Patil A; Mostaghiman R; Golpour M J Cosmet Dermatol; 2023 Jun; 22(6):1774-1779. PubMed ID: 36847668 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]